Advertisement
Case review

Depression and anxiety in patients with COPD

Megan Kalucy, Daniel Wang

Figures

© AMENIC181/STOCK.ADOBE.COM. MODEL USED FOR ILLUSTRATIVE PURPOSES ONLY
© AMENIC181/STOCK.ADOBE.COM. MODEL USED FOR ILLUSTRATIVE PURPOSES ONLY

Abstract

Depression and anxiety are common in people with chronic obstructive pulmonary disease and are associated with significant distress, increased morbidity and mortality, and reduced functioning and quality of life.

Key Points

  • There is a bidirectional relationship between depression and medical illness.
  • Comorbid depression and anxiety are associated with more severe medical illness, increased morbidity and mortality, increased functional disability and poorer quality of life.
  • Comorbid depression is associated with increased presentations to healthcare services and increased costs of care.
  • Treating depression and anxiety may reverse this cascade.
  • All patients with obstructive pulmonary disease should be screened for depression and anxiety.
  • Recommended treatments include antidepressants, psychotherapy and pulmonary rehabilitation, although evidence is limited.
  • Any other medications or medical conditions that might be contributing to depression should be identified and managed.

Figures

© AMENIC181/STOCK.ADOBE.COM. MODEL USED FOR ILLUSTRATIVE PURPOSES ONLY
© AMENIC181/STOCK.ADOBE.COM. MODEL USED FOR ILLUSTRATIVE PURPOSES ONLY